GMT CAPITAL CORP – Celldex Therapeutics, Inc. Transaction History
GMT CAPITAL CORP portfolio value:
$5.74M
portfolio value
GMT CAPITAL CORP quarter portfolio value change:
+4.27%
quarter
Celldex Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 235K | $28.11 | 204.53K | |
| Q2 2022 | share | 0.00% | 0 shares | -1.45M | $26.96 | 204.53K | |
| Q1 2022 | share | Increase | 0.00% | 204.53K shares | 6.96M | $34.06 | 204.53K |